WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹227 Cr | ₹167 Cr | ₹136 Cr | ₹117 Cr | ₹111 Cr |
What is the latest Sundry Debtors ratio of WINDLAS BIOTECH ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹227 Cr |
| Mar2025 | ₹167 Cr |
| Mar2024 | ₹136 Cr |
| Mar2023 | ₹117 Cr |
| Mar2022 | ₹111 Cr |
How is Sundry Debtors of WINDLAS BIOTECH Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹227 Cr | 36.28 | |
| Mar2025 | ₹167 Cr | 22.44 | |
| Mar2024 | ₹136 Cr | 16.62 | |
| Mar2023 | ₹117 Cr | 5.50 | |
| Mar2022 | ₹111 Cr | - | |
Compare Sundry Debtors of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,755.3 Cr | -3.4% | 1.4% | -8.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -3.4% |
1.4% |
-8.5% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses